Interested in #EVs based research? 🔬 This webinar might be of interest! Today!! #ExtracellularVesicles #EVResearch #InnovativeTherapies #TargetedDrugDelivery #BiotechInnovation #ExosomeResearch #Vesiculab #KarolinskaInstitute #ScientificWebinar #EVTechnologies #DrugDeliverySolutions #ResearchTools #EVAnalysis #Biopharma #BiotechSolutions #TherapeuticAdvancements #EVApplications

Come and meet Véronique Laborde to discuss your API or Polymers development project

Discover exciting results on the performance of jetMESSENGER® to transfect T cells. The results were achieved after having optimized different parameters for jetMESSENGER reagent and following manufacturer’s instructions with Lipofectamine™ 2000 reagent. The data from this study show that when compared with Lipofectamine™ reagent 2000, jetMESSENGER® demonstrates excellent results, increasing GFP expression 8-fold while maintaining high cell viability. #Polyplus #Sartorius

Antibody-drug conjugates (ADCs) stand out as innovative biotherapeutics, but understanding their ADME properties during the discovery and development stages can be complex. This upcoming webinar can help! Join us today from 11:15 to 11:45 am, EST, as we share insights and strategies for ADC development at AAPS’s eCHALK webinar (free registration: https://hubs.li/Q02n6D9-0). Topics include: ✅ Payload release mechanisms ✅ Identification of catabolites in various in vitro systems ✅ Detection of drug–antibody ratios (DAR) ✅ The implementation of an integrated bioanalysis platform catering to both small and large molecules #aapscomms #adc #drugdiscovery #drugdesign #bioanalytical #dmpk #adme

Haemostasis / coagulation testing is used to monitor the ability of a patient’s blood to clot appropriately, which can determine the risk of excessive bleeding or developing clots (thrombosis). Amongst the various types of coagulation tests available, viscoelastic devices have experienced significant growth in recent years given their ability to run multiple tests simultaneously and provide a full coagulation profile in point-of-care settings. IBEX Technologies patented enzyme technologies and esteemed position in the In Vitro Diagnostics (IVD) industry made them the perfect partner for BBI Solutions to enhance their portfolio of recombinant proteins and broaden their North American presence. Crosstree acted as the exclusive financial advisor to BBI Solutions in this transaction. Read more about this partnership in our Deal Insights: https://hubs.li/Q02D1Rf10 #strategyconsulting #diagnostics #mergersandacquisitions #diagnosticmedicine Michael Levin

🚀 MedChemExpress LLC's new #product series is here!  We are launching several #innovative #molecules, including the novel fourth-generation #EGFR #inhibitor BI-4732, the orally active #PTDSS1 inhibitor DS55980254, and PCSK9 inhibitor DC371739. Also noteworthy are the targeted molecules #BAY1214784 and #uPSEM792, which exhibit excellent affinity. Looking forward to injecting #new #vitality and hope into #drug development! For More Information: https://lnkd.in/eXGE3XQC

Innate Pharma has developed a new antibody-drug conjugate (ADC) coupling technology. Using the ProteoStat® Thermal Shift Stability Assay to measure TAgg of ADC products confirmed that the stability of an ADC is largely dependent on the number of toxins conjugated to the antibody and the lipophilic nature of the linkers used to conjugate these toxins. Application of the ProteoStat® dye resulted in the successful prediction of the propensity for aggregation of ADCs; thereby, validating Innate Pharma’s coupling technology as an ideal platform for the development of stable, robust ADC products. Dive into the details with our application note: https://lnkd.in/eyM3BS_5 ?utm_source=2024-08-10-ADC-P9.2&utm_medium=social&utm_campaign=ADC #ScientistsEnablingScientist #ADC #Services #Bioprocess #Biomanufacturing

Antibody-drug conjugates (ADCs) stand out as innovative biotherapeutics, but understanding their ADME properties during the discovery and development stages can be complex. This upcoming webinar can help! Join us today from 11:15 to 11:45 am, EST, as we share insights and strategies for ADC development at AAPS’s eCHALK webinar (free registration: https://hubs.li/Q02pSkjq0). Topics include: ✅ Payload release mechanisms ✅ Identification of catabolites in various in vitro systems ✅ Detection of drug–antibody ratios (DAR) ✅ The implementation of an integrated bioanalysis platform catering to both small and large molecules #aapscomms #adc #drugdiscovery #drugdesign #bioanalytical #dmpk #adme

New Hopes For Gout Patients Worldwide – AR882! Arthrosi Therapeutics, Inc., an HKSTP Venture Fund-backed biotech company, has received FDA Fast Track Designation for AR882 in tophaceous gout - a potentially best-in-class treatment for gout. Clinical trials have shown that AR882 can significantly reduce serum urate levels, flares and tophi in patients with gout compared to existing treatments. With more than 50 million people globally suffering from this painful form of arthritis, AR882's highly potent and selective next-generation URAT1 inhibitor is a sign of hope for many. We're proud to support Hong Kong’s biomedical breakthroughs, cultivating solutions like this that improve lives worldwide. Struggling to translate quality research into good business? We can help: stp.hk/4efiIxd #HKSTP #PropellingSuccess #BioTech

Antibody-drug conjugates (ADCs) stand out as innovative biotherapeutics, but understanding their ADME properties during the discovery and development stages can be complex. This upcoming webinar can help! Join us on March 20th from 11:15 to 11:45 am, EST, as we share insights and strategies for ADC development at AAPS’s eCHALK webinar (free registration: https://hubs.li/Q02n6CLb0). Topics include: ✅ Payload release mechanisms ✅ Identification of catabolites in various in vitro systems ✅ Detection of drug–antibody ratios (DAR) ✅ The implementation of an integrated bioanalysis platform catering to both small and large molecules #aapscomms #adc #drugdiscovery #drugdesign #bioanalytical #dmpk #adme